Dual Status Rx/OTC Plan B In The Works? Barr Weighs Its Options
Barr appears to be leaning toward a dual label Rx/OTC approach in seeking FDA approval to switch the emergency contraceptive Plan B (levonorgestrel)
Barr appears to be leaning toward a dual label Rx/OTC approach in seeking FDA approval to switch the emergency contraceptive Plan B (levonorgestrel)